{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T18:49:04Z","timestamp":1649011744812},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,2,3]],"date-time":"2011-02-03T00:00:00Z","timestamp":1296691200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Doc Ophthalmol"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1007\/s10633-011-9262-5","type":"journal-article","created":{"date-parts":[[2011,2,2]],"date-time":"2011-02-02T04:23:55Z","timestamp":1296620635000},"page":"77-86","source":"Crossref","is-referenced-by-count":2,"title":["Retinal disorders in northern Brazilian patients treated with chloroquine assessed by multifocal ERG"],"prefix":"10.1007","volume":"122","author":[{"given":"M.","family":"Raster","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Horn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"J\u00fcnemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. A. M.","family":"Rosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. S.","family":"Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. D.","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. G.","family":"Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. C. L.","family":"Silveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Kremers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,2,3]]},"reference":[{"key":"9262_CR1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10633-005-7349-6","volume":"110","author":"R Tzekov","year":"2005","unstructured":"Tzekov R (2005) Ocular toxicity due to chloroquine and hydroxychloroquine: electrophysiological and visual function correlates. Doc Ophthalmol 110:111\u2013120","journal-title":"Doc Ophthalmol"},{"key":"9262_CR2","unstructured":"Ministeri\u00f3 da Sa\u00fade B (2001) Ministeri\u00f3 da Sa\u00fade. Manual de terap\u00eautica da mal\u00e1ria, Brasil"},{"key":"9262_CR3","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3949\/ccjm.25.2.95","volume":"25","author":"AL Scherbel","year":"1958","unstructured":"Scherbel AL, Harrison JW, Atdjian M (1958) Further observations on the use of 4-aminoquinoline compounds in patients with rheumatoid arthritis or related diseases. Clevel Clin Q 25:95\u2013111","journal-title":"Clevel Clin Q"},{"key":"9262_CR4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0002-9343(83)91265-2","volume":"75","author":"EW McChesney","year":"1983","unstructured":"McChesney EW (1983) Animal toxicity and pharmacokinetics of hydroxychloroquine sulfate. Am J Med 75:11\u201318","journal-title":"Am J Med"},{"key":"9262_CR5","unstructured":"Ministeri\u00f3 da Sa\u00fade B (2010) Ministeri\u00f3 da Sa\u00fade Brasil Secretaria de vigil\u00e2ncia em sa\u00fade Departamento de vigil\u00e2ncia epidemiol\u00f3gica. Guia pr\u00e1tico de tratamento da mal\u00e1ria no Brasil"},{"key":"9262_CR6","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1086\/322858","volume":"184","author":"TE Wellems","year":"2001","unstructured":"Wellems TE, Plowe CV (2001) Chloroquine resistant malaria. J Infect Dis 184:770\u2013776","journal-title":"J Infect Dis"},{"key":"9262_CR7","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1056\/NEJMoa062032","volume":"355","author":"MK Laufer","year":"2006","unstructured":"Laufer MK, Thesing PC, Eddington ND, Masonga R, Dzinjalamala FK, Takala SL, Taylor TE, Plowe CV (2006) Return of chloroquine antimalarial efficacy in Malawi. N Engl J Med 355:1959\u20131966","journal-title":"N Engl J Med"},{"key":"9262_CR8","doi-asserted-by":"crossref","unstructured":"Plowe CV (2005) Antimalarial drug resistance in Africa: strategies for monitoring and deterrence. In: Compans RW, Cooper MD, Honjo T, Koprowski H, Melchers F, Oldstone MBA, Olsnes S, Potter M, Vogt PK, Wagner H, Sullivan DJ, Krishna S (eds) Current topics in microbiology and immunology. WHO Technical Report Series, pp 55\u201379","DOI":"10.1007\/3-540-29088-5_3"},{"key":"9262_CR9","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s004170050016","volume":"238","author":"U Kellner","year":"2000","unstructured":"Kellner U, Kraus H, Foerster MH (2000) Multifocal ERG in chloroquine retinopathy: regional variance of retinal dysfunction. Graefes Arch Clin Exp Ophthalmol 238:94\u201397","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"9262_CR10","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S0161-6420(02)01168-5","volume":"109","author":"MF Marmor","year":"2002","unstructured":"Marmor MF, Carr RE, Easterbrook M, Farjo AA, Mieler WF (2002) Recommendations on screening for chloroquine and hydroxychloroquine retinopathy: a report by the American Academy of Ophthalmology. Ophthalmology 109:1377\u20131382","journal-title":"Ophthalmology"},{"key":"9262_CR11","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0002-9394(67)92518-4","volume":"64","author":"RV Shearer","year":"1967","unstructured":"Shearer RV, Dubois EL (1967) Ocular changes induced by long-term hydroxychloroquine (plaquenil) therapy. Am J Ophthalmol 64:245\u2013252","journal-title":"Am J Ophthalmol"},{"key":"9262_CR12","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1001\/archopht.1982.01030030083006","volume":"100","author":"R Tobin","year":"1982","unstructured":"Tobin R, Krobel GB, Ryners RI (1982) Hydroxychloroquine: seven years experience. Arch Ophthalmol 100:81\u201383","journal-title":"Arch Ophthalmol"},{"key":"9262_CR13","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1755-3768.1966.tb08039.x","volume":"44","author":"U Nylander","year":"1966","unstructured":"Nylander U (1966) Ocular damage in chloroquine therapy. Acta Ophthalmol (Copenh) 44:335\u2013348","journal-title":"Acta Ophthalmol (Copenh)"},{"issue":"Suppl","key":"9262_CR14","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/0002-9343(83)91269-X","volume":"75","author":"AH Mackenzie","year":"1983","unstructured":"Mackenzie AH (1983) Dose refinements in long-term therapy of rheumatoid arthritis with antimalarials. Am J Med 75(Suppl):40\u201345","journal-title":"Am J Med"},{"key":"9262_CR15","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1136\/ard.55.3.187","volume":"55","author":"M Mavrikakis","year":"1996","unstructured":"Mavrikakis M, Papazoglou S, Sfikakis PP, Vaiopoulos G, Rougas K (1996) Retinal toxicity in long term hydroxychloroquine treatment. Ann Rheum Dis 55:187\u2013189","journal-title":"Ann Rheum Dis"},{"key":"9262_CR16","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1444-0938.2000.tb05072.x","volume":"83","author":"HS Weisinger","year":"2000","unstructured":"Weisinger HS, Pesudovs K, Collin HB (2000) Management of patients undergoing hydroxychloroquine (Plaquenil) therapy. Clin Exp Optom 83:32\u201336","journal-title":"Clin Exp Optom"},{"key":"9262_CR17","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0002-9394(87)90005-5","volume":"104","author":"MW Johnson","year":"1987","unstructured":"Johnson MW, Vine AK (1987) Hydroxychloroquine therapy in massive total doses without retinal toxicity. Am J Ophthalmol 104:139\u2013144","journal-title":"Am J Ophthalmol"},{"key":"9262_CR18","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0002-9343(88)90358-0","volume":"85","author":"M Easterbrook","year":"1988","unstructured":"Easterbrook M (1988) Ocular effects and safety of antimalarial agents. Am J Med 85:23\u201329","journal-title":"Am J Med"},{"key":"9262_CR19","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1167\/iovs.05-1290","volume":"47","author":"U Kellner","year":"2006","unstructured":"Kellner U, Renner AB, Tillack H (2006) Fundus autofluorescence and mfERG for early detection of retinal alterations in patients using chloroquine\/hydroxychloroquine. Invest Ophthalmol Vis Sci 47:3531\u20133538","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"9262_CR20","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3928\/1542-8877-20030501-20","volume":"34","author":"SC So","year":"2003","unstructured":"So SC, Hedges TR, Schuman JS, Quireza ML (2003) Evaluation of hydroxychloroquine retinopathy with multifocal electroretinography. Ophthalmic Surg Lasers Imaging 34:251\u2013258","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"9262_CR21","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1001\/archopht.122.7.973","volume":"122","author":"RK Maturi","year":"2004","unstructured":"Maturi RK, Yu M, Weleber R (2004) Multifocal electroretinographic evaluation of long-term hydroxychloroquine users. Arch Ophthalmol 122:973\u2013981","journal-title":"Arch Ophthalmol"},{"key":"9262_CR22","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/00006982-200308000-00010","volume":"23","author":"PJ Penrose","year":"2003","unstructured":"Penrose PJ, Tzekov R, Sutter EE, Fu AD, Allen AW Jr, Fung W, Oxford KW (2003) Multifocal electroretinography evaluation for early detection of retinal dysfunction in patients taking hydroxychloroquine. Retina 23:503\u2013512","journal-title":"Retina"},{"key":"9262_CR23","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10633-007-9105-6","volume":"116","author":"U Kellner","year":"2008","unstructured":"Kellner U, Kellner S, Weinitz S (2008) Chloroquine retinopathy: lipofuscin- and melanin-related fundus autofluorescence, optical coherence tomography and multifocal electroretinography. Doc Ophthalmol 116:119\u2013127","journal-title":"Doc Ophthalmol"},{"key":"9262_CR24","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0042-6989(92)90235-B","volume":"32","author":"EE Sutter","year":"1992","unstructured":"Sutter EE, Tran D (1992) The field topography of ERG components in man-I. The photopic luminance response. Vis Res 32:433\u2013446","journal-title":"Vis Res"},{"key":"9262_CR25","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1023\/B:DOOP.0000018410.08802.d3","volume":"108","author":"RT Tzekov","year":"2004","unstructured":"Tzekov RT, Serrato A, Marmor MF (2004) ERG findings in patients using hydroxychloroquine. Doc Ophthalmol 108:87\u201397","journal-title":"Doc Ophthalmol"},{"key":"9262_CR26","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1023\/B:DOOP.0000018385.99215.0d","volume":"108","author":"MN Moschos","year":"2004","unstructured":"Moschos MN, Moschos MM, Apostolopoulos M, Mallias JA, Bouros C, Theodossiadis GP (2004) Assessing hydroxychloroquine toxicity by the multifocal ERG. Doc Ophthalmol 108:47\u201353","journal-title":"Doc Ophthalmol"},{"key":"9262_CR27","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000076890","volume":"36","author":"AS Neubauer","year":"2004","unstructured":"Neubauer AS, Stiefelmeyer S, Berninger TA, Arden G, Rudolph G (2004) The multifocal pattern electroretinogram in chloroquine retinopathy. Ophthalmic Res 36:106\u2013113","journal-title":"Ophthalmic Res"},{"key":"9262_CR28","unstructured":"Kertes PJ, Coupland SE, Leonard BC, Bhargava SK (2003) Multifocal ERG changes secondary to chloroquine and plaquenil toxicity. Invest Ophthalmol Vis Sci 44: E-Abstract 2701"},{"key":"9262_CR29","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00347-007-1560-7","volume":"104","author":"K Ruther","year":"2007","unstructured":"Ruther K, Foerster J, Berndt S, Schroeter J (2007) Chloroquine\/hydroxychloroquine: variability of retinotoxic cumulative doses. Ophthalmologe 104:875\u2013879","journal-title":"Ophthalmologe"},{"key":"9262_CR30","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1023\/A:1022591317907","volume":"106","author":"MF Marmor","year":"2003","unstructured":"Marmor MF, Hood DC, Keating D, Kondo M, Seeliger MW, Miyake Y (2003) Guidelines for basic multifocal electroretinography (mfERG). Doc Ophthalmol 106:105\u2013115","journal-title":"Doc Ophthalmol"},{"key":"9262_CR31","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.ajo.2006.12.042","volume":"143","author":"JS Lyons","year":"2007","unstructured":"Lyons JS, Severns ML (2007) Detection of early hydroxychloroquine retinal toxicity enhanced by ring ratio analysis of multifocal electroretinography. Am J Ophthalmol 143:801\u2013809","journal-title":"Am J Ophthalmol"},{"key":"9262_CR32","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1364\/JOSAA.13.000634","volume":"13","author":"MA Bearse Jr","year":"1996","unstructured":"Bearse MA Jr, Sutter EE (1996) Imaging localized retinal dysfunction with the multifocal electroretinogram. J Opt Soc Am A Opt Image Sci Vis 13:634\u2013640","journal-title":"J Opt Soc Am A Opt Image Sci Vis"},{"key":"9262_CR33","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10633-009-9205-6","volume":"120","author":"AR Rodrigues","year":"2010","unstructured":"Rodrigues AR, Da Silva Filho M, Silveira LC, Kremers J (2010) Spatial distributions of on- and off-responses determined with the multifocal ERG. Doc Ophthalmol 120:145\u2013158","journal-title":"Doc Ophthalmol"},{"key":"9262_CR34","first-page":"1673","volume":"43","author":"DC Hood","year":"2002","unstructured":"Hood DC, Frishman LJ, Saszik S, Viswanathan S (2002) Retinal origins of the primate multifocal ERG: implications for the human response. Invest Ophthalmol Vis Sci 43:1673\u20131685","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"9262_CR35","volume-title":"Retina","author":"JE Thorne","year":"2006","unstructured":"Thorne JE, Jabs DA (2006) Rheumatic disease. In: Ryan SJ, Schachat AP (eds) Retina. Mosby, St. Louis"},{"key":"9262_CR36","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/BF00145368","volume":"47","author":"S Lessel","year":"1979","unstructured":"Lessel S (1979) The neuro-ophthalmology of systemic lupus erythematosus. Doc Ophthalmol 47:13\u201342","journal-title":"Doc Ophthalmol"},{"key":"9262_CR37","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1001\/archopht.1964.00970010254019","volume":"71","author":"HN Bernstein","year":"1964","unstructured":"Bernstein HN, Ginsberg J (1964) The pathology of chloroquine retinopathy. Arch Ophthalmol 71:238\u2013245","journal-title":"Arch Ophthalmol"},{"key":"9262_CR38","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1001\/archopht.1964.00970010098016","volume":"71","author":"DH Wetterholm","year":"1964","unstructured":"Wetterholm DH, Winter FC (1964) Histopathology of chloroquine retinal toxicity. Arch Ophthalmol 71:82\u201387","journal-title":"Arch Ophthalmol"},{"key":"9262_CR39","first-page":"1158","volume":"17","author":"AR Rosenthal","year":"1978","unstructured":"Rosenthal AR, Kolb H, Bergsma D, Huxsoll D, Hopkins JL (1978) Chloroquine retinopathy in the rhesus monkey. Invest Ophthalmol Vis Sci 17:1158\u20131175","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"9262_CR40","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0002-9394(01)00838-8","volume":"131","author":"NF Shroyer","year":"2001","unstructured":"Shroyer NF, Lewis RA, Lupski JR (2001) Analysis of the ABCR (ABCA4) gene in 4-aminoquinoline retinopathy: is retinal toxicity by chloroquine and hydroxychloroquine related to Stargardt disease? Am J Ophthalmol 131:761\u2013766","journal-title":"Am J Ophthalmol"},{"key":"9262_CR41","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-1-4419-5635-4_8","volume":"703","author":"Y Tsybovsky","year":"2010","unstructured":"Tsybovsky Y, Molday RS, Palczewski K (2010) The ATP-binding cassette transporter ABCA4: structural and functional properties and role in retinal disease. Adv Exp Med Biol 703:105\u2013125","journal-title":"Adv Exp Med Biol"}],"container-title":["Documenta Ophthalmologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10633-011-9262-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10633-011-9262-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10633-011-9262-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T04:26:28Z","timestamp":1559967988000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10633-011-9262-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,3]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["9262"],"URL":"https:\/\/doi.org\/10.1007\/s10633-011-9262-5","relation":{},"ISSN":["0012-4486","1573-2622"],"issn-type":[{"value":"0012-4486","type":"print"},{"value":"1573-2622","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,3]]}}}